MY159317A - Treating idiopathic thrombocytopenic purpura with compositions comprising extracts of astragalus membranaceus - Google Patents
Treating idiopathic thrombocytopenic purpura with compositions comprising extracts of astragalus membranaceusInfo
- Publication number
- MY159317A MY159317A MYPI2011002701A MYPI2011002701A MY159317A MY 159317 A MY159317 A MY 159317A MY PI2011002701 A MYPI2011002701 A MY PI2011002701A MY PI2011002701 A MYPI2011002701 A MY PI2011002701A MY 159317 A MY159317 A MY 159317A
- Authority
- MY
- Malaysia
- Prior art keywords
- extracts
- compositions
- thrombocytopenic purpura
- idiopathic thrombocytopenic
- astragalus membranaceus
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 5
- 235000006533 astragalus Nutrition 0.000 title abstract 3
- 239000000284 extract Substances 0.000 title abstract 3
- 241000045403 Astragalus propinquus Species 0.000 title abstract 2
- 206010021245 Idiopathic thrombocytopenic purpura Diseases 0.000 title abstract 2
- 208000031981 Thrombocytopenic Idiopathic Purpura Diseases 0.000 title abstract 2
- 201000003710 autoimmune thrombocytopenic purpura Diseases 0.000 title abstract 2
- 229930182830 galactose Natural products 0.000 abstract 2
- 238000011282 treatment Methods 0.000 abstract 2
- SATHPVQTSSUFFW-UHFFFAOYSA-N 4-[6-[(3,5-dihydroxy-4-methoxyoxan-2-yl)oxymethyl]-3,5-dihydroxy-4-methoxyoxan-2-yl]oxy-2-(hydroxymethyl)-6-methyloxane-3,5-diol Chemical class OC1C(OC)C(O)COC1OCC1C(O)C(OC)C(O)C(OC2C(C(CO)OC(C)C2O)O)O1 SATHPVQTSSUFFW-UHFFFAOYSA-N 0.000 abstract 1
- 241001061264 Astragalus Species 0.000 abstract 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 abstract 1
- PNNNRSAQSRJVSB-BXKVDMCESA-N aldehydo-L-rhamnose Chemical compound C[C@H](O)[C@H](O)[C@@H](O)[C@@H](O)C=O PNNNRSAQSRJVSB-BXKVDMCESA-N 0.000 abstract 1
- 108010054251 arabinogalactan proteins Proteins 0.000 abstract 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 abstract 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 239000008103 glucose Substances 0.000 abstract 1
- 210000004233 talus Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1816—Erythropoietin [EPO]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/193—Colony stimulating factors [CSF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/196—Thrombopoietin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/202—IL-3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12258608P | 2008-12-15 | 2008-12-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY159317A true MY159317A (en) | 2016-12-30 |
Family
ID=42266446
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI2011002701A MY159317A (en) | 2008-12-15 | 2009-12-15 | Treating idiopathic thrombocytopenic purpura with compositions comprising extracts of astragalus membranaceus |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US8137710B2 (enExample) |
| EP (1) | EP2376096B1 (enExample) |
| JP (1) | JP5732604B2 (enExample) |
| KR (1) | KR101780074B1 (enExample) |
| CN (1) | CN102300576B (enExample) |
| MY (1) | MY159317A (enExample) |
| SG (1) | SG172029A1 (enExample) |
| TW (1) | TWI507201B (enExample) |
| WO (1) | WO2010077867A2 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103142726A (zh) * | 2013-02-21 | 2013-06-12 | 上海浦东高星生物技术研究所 | 溃疡止血粉 |
| JP2017525702A (ja) * | 2014-08-18 | 2017-09-07 | ファーマジェネシス， インコーポレイテッド | ポリガラクツロナンラムノガラクツロナン（ｐｇｒｇ１）組成物 |
| CN104173563A (zh) * | 2014-08-22 | 2014-12-03 | 上海中医药大学附属岳阳中西医结合医院 | 一种治疗免疫性血小板减少症的中药组合物 |
| CN104740405B (zh) * | 2015-04-14 | 2018-09-04 | 日照市中医医院 | 一种治疗过敏性紫癜性肾损害的中药制剂及制备方法 |
| CN104784419A (zh) * | 2015-04-24 | 2015-07-22 | 陕西郝其军制药股份有限公司 | 一种治疗免疫性血小板减少性紫癜的中药组合物及其制备方法 |
| CN108066354A (zh) * | 2016-11-10 | 2018-05-25 | 怀特生技新药股份有限公司 | 黄芪多糖萃取物在制备用于增强癌症免疫疗法功效的药物中的用途 |
| CN109199907A (zh) * | 2017-07-07 | 2019-01-15 | 怀特生技新药股份有限公司 | 黄芪萃取物在制备用于抑制黑色素生成的组合物中的应用 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4708949A (en) * | 1985-09-24 | 1987-11-24 | Yaguang Liu | Therapeutic composition from plant extracts |
| US4795742A (en) * | 1985-09-24 | 1989-01-03 | Yaguang Liu | Therapeutic composition from plant extracts |
| US5336506A (en) * | 1986-07-03 | 1994-08-09 | Advanced Magnetics Inc. | Targeting of therapeutic agents using polysaccharides |
| US5679323A (en) * | 1986-07-03 | 1997-10-21 | Advanced Magnetics, Inc. | Hepatocyte-specific receptor-mediated endocytosis-type compositions |
| US5478576A (en) * | 1986-07-03 | 1995-12-26 | Advanced Magnetics, Inc. | Arabinogalactan derivatives and uses thereof |
| US5589591A (en) * | 1986-07-03 | 1996-12-31 | Advanced Magnetics, Inc. | Endotoxin-free polysaccharides |
| US5554386A (en) * | 1986-07-03 | 1996-09-10 | Advanced Magnetics, Inc. | Delivery of therapeutic agents to receptors using polysaccharides |
| US4843067A (en) * | 1986-11-19 | 1989-06-27 | Yaguang Liu | Polysaccharide containing pharmaceutical composition for increasing the immune function |
| US4944946A (en) * | 1987-01-27 | 1990-07-31 | Yaguang Liu | Pharmaceutical composition for inhibiting viruses and increasing immune function (PII) |
| US5268467A (en) * | 1988-05-23 | 1993-12-07 | Verbiscar Anthony J | Immunomodulatory polysaccharide fractions from Astragalus plants |
| CN1027168C (zh) | 1989-05-13 | 1994-12-28 | 储大同 | 一种黄芪有效成分的提取方法 |
| US4950751A (en) * | 1989-06-02 | 1990-08-21 | The Nanci Corporation International | Method of isolating arabinogalactan from larch |
| IT1238685B (it) | 1990-02-09 | 1993-09-01 | Indena Spa | Polisaccaridi ad azione immunomodulatrice da astragalus membranaceous e composizioni farmaceutiche che li contengono |
| US5116969B1 (en) * | 1990-04-26 | 1997-04-01 | Larex International Inc | Ultrarefined arabinogalactan product |
| CN1025590C (zh) | 1990-07-20 | 1994-08-10 | 邓恺 | 肛瘘注射液的制备方法 |
| ES2049561B1 (es) | 1991-04-27 | 1994-12-16 | Andromaco Lab | Procedimiento para la obtencion de polimeros con actividad sobre el sistema hematopoyetico. |
| US5547997A (en) | 1991-10-01 | 1996-08-20 | Chemisches Laboratorium Dr. Kurt Richter Gmbh | Plant-derived cosmetic composition and method of treatment of skin |
| US5646029A (en) * | 1993-12-03 | 1997-07-08 | Cooperative Research Centre For Industrial Plant Biopolymers | Plant arabinogalactan protein (AGP) genes |
| US5756098A (en) * | 1995-12-12 | 1998-05-26 | The University Of Montana | Methods for the extraction of phytochemicals from fibrous plants in the absence of solvent |
| KR100195884B1 (ko) | 1996-02-12 | 1999-06-15 | 김박광 | 황기 추출물을 함유하는 혈당강하제 조성물 및 황기 추출물의 제조방법 |
| US5770217A (en) * | 1997-07-02 | 1998-06-23 | Atlatl, Inc. | Dietary supplement for hematological, immune and appetite enhancement |
| EP1200482A1 (en) * | 1999-06-30 | 2002-05-02 | Pharmagenesis, Inc. | Hematopoietic arabinogalactan composition |
| KR20030021176A (ko) * | 2000-06-29 | 2003-03-12 | 파마제네시스 인코포레이티드 | 산으로 개질된 아라비노갈락탄 단백질 조성물 |
| KR100440863B1 (ko) | 2001-05-24 | 2004-07-19 | 한국원자력연구소 | 조혈기능 증진 및 방사선 방호용 생약추출물 |
| KR100526404B1 (ko) | 2003-07-31 | 2005-11-08 | 학교법인 한림대학교 | 황기 추출물을 포함하는 뇌허혈성 신경세포손상 방지용조성물 |
| KR100449655B1 (ko) | 2003-11-17 | 2004-09-20 | 한국원자력연구소 | 조혈 및 면역기능 증강 및 방사선 방호용 기능성 식품 |
| JP2006070217A (ja) * | 2004-09-03 | 2006-03-16 | Kitasato Inst:The | オウギ属植物地上部由来の多糖および生体防御機能賦活化剤 |
| KR100697212B1 (ko) | 2005-01-29 | 2007-03-22 | 서울향료(주) | 황기 및 당귀의 혼합 생약재 추출물을 유효성분으로 하는,항암제 투여에 의해 유발되는 부작용 치료용 조혈 촉진제 |
| KR100760384B1 (ko) | 2006-02-22 | 2007-09-19 | 경희대학교 산학협력단 | 황기 추출물을 포함하는 혈관형성 촉진 및 골유합 효과를갖는 골절의 예방 및 치료용 조성물 |
-
2009
- 2009-12-15 JP JP2011540971A patent/JP5732604B2/ja active Active
- 2009-12-15 SG SG2011041787A patent/SG172029A1/en unknown
- 2009-12-15 WO PCT/US2009/068062 patent/WO2010077867A2/en not_active Ceased
- 2009-12-15 TW TW098143056A patent/TWI507201B/zh active
- 2009-12-15 KR KR1020117016274A patent/KR101780074B1/ko active Active
- 2009-12-15 CN CN200980155742.9A patent/CN102300576B/zh active Active
- 2009-12-15 EP EP09836839.2A patent/EP2376096B1/en active Active
- 2009-12-15 US US12/638,845 patent/US8137710B2/en active Active
- 2009-12-15 MY MYPI2011002701A patent/MY159317A/en unknown
-
2012
- 2012-02-07 US US13/368,319 patent/US8728543B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| SG172029A1 (en) | 2011-07-28 |
| US20100158861A1 (en) | 2010-06-24 |
| WO2010077867A3 (en) | 2010-11-25 |
| KR101780074B1 (ko) | 2017-09-19 |
| WO2010077867A2 (en) | 2010-07-08 |
| US8137710B2 (en) | 2012-03-20 |
| CN102300576B (zh) | 2014-03-05 |
| EP2376096A4 (en) | 2013-10-02 |
| US8728543B2 (en) | 2014-05-20 |
| JP5732604B2 (ja) | 2015-06-10 |
| JP2012512176A (ja) | 2012-05-31 |
| TWI507201B (zh) | 2015-11-11 |
| TW201026318A (en) | 2010-07-16 |
| EP2376096B1 (en) | 2019-07-24 |
| EP2376096A2 (en) | 2011-10-19 |
| KR20110094343A (ko) | 2011-08-23 |
| US20120141412A1 (en) | 2012-06-07 |
| CN102300576A (zh) | 2011-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2010077867A3 (en) | Treating idiopathic thrombocytopenic purpura with compositions comprising extracts of astragalus membranaceus | |
| CA2863681A1 (en) | Topical use of a skin-commensal prebiotic agent and compositions containing the same | |
| NZ600118A (en) | Lipopeptide compositions and related methods | |
| PH12013500136A1 (en) | Immunogenic composition | |
| EP4545070A3 (en) | Particles comprising a therapeutic or diagnostic agent and suspensions and methods of use thereof | |
| MX2021005365A (es) | Preparaciones y composiciones de oligosacaridos. | |
| BRPI0820308B8 (pt) | composição farmacêutica compreendendo oxi-hidróxido de ferro em alta carga, seus usos e seus processos de preparação, e comprimido | |
| TW200833351A (en) | New cosmetic and/or pharmaceutical compositions and their applications | |
| IN2012DN01638A (enExample) | ||
| WO2008030567A3 (en) | Dry powder compound formulations and uses thereof | |
| MY143795A (en) | Tetrahydropyridoindole derivatives | |
| WO2009128918A8 (en) | Combination therapy using a soluble hyaluronidase and a bisphosphonate | |
| SG146648A1 (en) | Pharmaceutical compositions for treating premature ejaculation by pulmonary inhalation | |
| WO2011035335A3 (en) | Stabilized liquid and lyophilized adamts13 formulations | |
| MY159379A (en) | Composition for human and/or animal nutrition, uses thereof and yeasts | |
| WO2008036932A3 (en) | Compositions and methods comprising boswellia species | |
| WO2009131730A3 (en) | IMMUNOGENIC COMPOSITIONS FOR ACTIVATING γδ T CELLS | |
| WO2007127273A3 (en) | Methods and compositions for altering cell function | |
| PH12013500485A1 (en) | Fabric treatment compositions comprising target benefit agents | |
| BR112019017393A2 (pt) | formulações de evolocumab de baixa viscosidade, alta concentração e métodos para produzir as mesmas | |
| WO2007092343A3 (en) | Novel epoprostenol formulation and method of making thereof | |
| WO2009130616A3 (en) | Improved tlr3 agonist compositions | |
| CN104586686A (zh) | 一种净白护肤水 | |
| WO2008062467A3 (en) | Cultured melanocytes on biopolymers | |
| WO2014131739A3 (en) | Substituted imidazopyridazines |